Wednesday, November 18, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Exports

HitGen and SPARC Enter DNA-Encoded Library Based Research

Fiinews by Fiinews
March 13, 2019
in Exports, Health, Manufacturing
Reading Time: 2 mins read
A A
0
0
SHARES
11
VIEWS
LinkedinShare on Twitter

Chengdu-Mumbai Drug Research Collaboration

 

HitGen.

HitGen Ltd and Sun Pharma Advanced Research Company Ltd have announced a research collaboration to identify novel small molecule leads for targets of interest.

Under this collaboration, announced 12 Mar 2019, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for SPARC. Under the terms of the agreement, HitGen will receive upfront payment and will be eligible for certain milestone payments.

“We are delighted to enter into collaboration with SPARC, a global pharmaceutical company headquartered in Mumbai. This collaboration further emphasizes the role of HitGen in the rapidly developing field of DNA-encoded chemistry,” said Dr. Jin Li, Chairman of the Board and Chief Executive Officer of HitGen.

“We will work closely with SPARC scientists to generate novel leads for their innovative research programs to address unmet medical needs,” Said Dr Li.

“We believe HitGen’s unique DNA-encoded library-based screening platform combined with SPARC’s in-house research expertise, shall accelerate our drug discovery efforts. We look forward to collaborating with HitGen to bring innovative medicines for patients with serious medical conditions.” said Anil Raghavan, CEO of SPARC.

HitGen is a rapidly growing biotech company with headquarters and main research facilities based in Chengdu, China and with a subsidiary in the USA.

HitGen has established a platform for small molecule drug discovery centred on the design, assembly and interrogation of DNA encoded chemical libraries (DELs).

HitGen’s DELs contain nearly 400 billion novel, diverse, drug-like small molecule and macrocyclic compounds. These compounds are members of DELs synthesised from many hundreds of distinct chemical scaffolds, designed with tractable chemistry, and yielding proven results for the discovery of small molecule leads against precedented and unprecedented classes of biological targets.

HitGen is collaborating with pharmaceutical, biotech, and chemical companies, foundations and research institutes in North America, Europe, Asia and Africa to discover and develop approaches for novel medicines and agrochemical solutions.

Sun Pharma Advanced Research Company Ltd is a global pharmaceutical company focused on continuously improving standards of care for patients globally through innovation in therapeutics and delivery.

SPARC aims to consistently lower costs and improve operational efficiencies to advance availability and affordability of cures for patients across the world. fiinews.com

Tags: Sun Pharma Advanced Research Company Ltd
ShareTweetShare

Related Posts

PIB
Exports

Export: India-Thailand traded $21.49bn in FY25-26

by Fiinews
November 18, 2026
0
26

Thailand presented its “Co-Creation Co-Investment” approach in Nonthaburi The India-Thailand bilateral trade reached USD21.49 billion in FY 2025–26, registering a...

PIB
Exports

Export: India-Egypt set $12bn bilateral trade target

by Fiinews
November 18, 2026
0
22

Ministers discussed supply chains and predictable trade pathways. Minister of Commerce and Industry Piyush Goyal and Dr Mohamed Farid Saleh,...

Vikram Solar

Manufacture: TN facility to produce from Dec 2026

November 16, 2026
18
ISNT

Manufacture: Minister wants strengthened NDT ecosystem

November 17, 2026
17
Indian Business Porftal

Export: Sustain growth in shipments, says FIOE Chief

November 16, 2026
24
NITI Aayog

Manufacture: PLI successful, says NITI Aayog

November 14, 2026
17
SBI YONO

Recent News

  • Market: Urban consumers prefer electric mobility
  • Invest: HZL to double production to 2 mtpa
  • Market: Rootstock expands in India through Conserve
  • Market: HGS-Rackspace to grow in high-value GCCs
  • Tech: DataSwitch’s Mathi automates data mapping

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.